De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
4013 Overzicht aandelen
Dr. Sulaiman Al Habib Medical Services Group Company richt ziekenhuizen, algemene en gespecialiseerde medische complexen, dagchirurgiecentra en farmaceutische faciliteiten op, beheert deze en exploiteert ze in Saoedi-Arabië en daarbuiten.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 2/6 |
| Toekomstige groei | 4/6 |
| Prestaties in het verleden | 3/6 |
| Financiële gezondheid | 3/6 |
| Dividenden | 1/6 |
Dr. Sulaiman Al Habib Medical Services Group Company Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | ر.س286.20 |
| 52 Week Hoogtepunt | ر.س346.80 |
| 52 Week Laag | ر.س223.20 |
| Bèta | 0.64 |
| 11 maand verandering | -7.14% |
| 3 maanden verandering | 1.13% |
| 1 Jaar Verandering | 22.10% |
| 33 jaar verandering | 69.55% |
| 5 jaar verandering | n/a |
| Verandering sinds IPO | 433.96% |
Recent nieuws en updates
Investors Will Want Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Growth In ROCE To Persist
Jul 04
Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 23Recent updates
Investors Will Want Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Growth In ROCE To Persist
Jul 04Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 23Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
May 08Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates
May 03Subdued Growth No Barrier To Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price
Apr 29There's Been No Shortage Of Growth Recently For Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Mar 15Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Dividend Will Be SAR1.15
Feb 22With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Feb 20Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price Is Out Of Tune With Earnings
Jan 09We Like These Underlying Return On Capital Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013)
Nov 28We Think That There Are Issues Underlying Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings
Nov 07Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 02Here's Why Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has Caught The Eye Of Investors
Sep 21Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Aug 10Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Well Worth Watching
Jun 17Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year
May 12Returns At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Are On The Way Up
May 06Here's Why We Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Mar 13Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital Are Heading Higher
Jan 30With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case
Dec 07Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Doing The Right Things To Multiply Its Share Price
Oct 23If EPS Growth Is Important To You, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Presents An Opportunity
Sep 08Estimating The Intrinsic Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Aug 24Why Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Could Be Worth Watching
Aug 08Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Has More To Do To Multiply In Value Going Forward
Jul 12Does Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Deserve A Spot On Your Watchlist?
May 31A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
May 17Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Will Pay A Larger Dividend Than Last Year At ر.س0.83
Apr 28Should You Think About Buying Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Now?
Apr 09Return Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Appealing
Mar 06Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is An Interesting Stock
Feb 16Returns On Capital At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Have Stalled
Dec 05Do Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Earnings Warrant Your Attention?
Nov 17Investors Could Be Concerned With Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital
Aug 30Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Aug 01Estimating The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Jun 11Capital Allocation Trends At Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Aren't Ideal
May 27Earnings Beat: Dr. Sulaiman Al Habib Medical Services Group Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 27Here's Why I Think Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Might Deserve Your Attention Today
Apr 06A Look At The Fair Value Of Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)
Feb 04Is Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Shareholder Ownership Skewed Towards Insiders?
Jan 14
Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Is Yielding 1.5% - But Is It A Buy?
Dec 23Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Nov 27Rendement voor aandeelhouders
| 4013 | SA Healthcare | SA Markt | |
|---|---|---|---|
| 7D | -4.0% | -4.1% | -1.4% |
| 1Y | 22.1% | 16.3% | -9.9% |
Rendement versus industrie: 4013 overtrof de SA Healthcare industrie, die het afgelopen jaar een rendement 16.3 % opleverde.
Rendement versus markt: 4013 overtrof de SA markt, die het afgelopen jaar een rendement opleverde van -10.4 %.
Prijsvolatiliteit
| 4013 volatility | |
|---|---|
| 4013 Average Weekly Movement | 2.9% |
| Healthcare Industry Average Movement | 5.0% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in SA Market | 7.6% |
| 10% least volatile stocks in SA Market | 2.7% |
Stabiele aandelenkoers: 4013 heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van 4013 is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1993 | n/a | Faisal Abdullah Al Nassar | www.hmg.com |
Dr. Sulaiman Al Habib Medical Services Group Company richt ziekenhuizen, algemene en gespecialiseerde medische complexen, dagchirurgiecentra en farmaceutische faciliteiten op, beheert deze en exploiteert ze in Saoedi-Arabië en daarbuiten. Het bedrijf exploiteert kraamklinieken en ziekenhuizen voor orthopedie en wervelkolomchirurgie. Het bedrijf exploiteert ook centra voor dermatologie, plastische chirurgie, oogheelkunde, behandeling van obesitas en vruchtbaarheid, en apotheken.
Dr. Sulaiman Al Habib Medical Services Group Company Samenvatting
| 4013 fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | ر.س100.31b |
| Inkomsten(TTM) | ر.س2.18b |
| Inkomsten(TTM) | ر.س10.02b |
46.0x
Koers/Winstverhouding10.0x
P/S-verhoudingIs 4013 overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| 4013 resultatenrekening (TTM) | |
|---|---|
| Inkomsten | ر.س10.02b |
| Kosten van inkomsten | ر.س6.57b |
| Brutowinst | ر.س3.45b |
| Overige uitgaven | ر.س1.27b |
| Inkomsten | ر.س2.18b |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 6.22 |
| Brutomarge | 34.42% |
| Nettowinstmarge | 21.70% |
| Schuld/Eigen Vermogen Verhouding | 78.6% |
Hoe presteerde 4013 op de lange termijn?
Bekijk historische prestaties en vergelijking